In vivo and ex vivo proofs of concept that cetuximab conjugated vitamin E TPGS micelles increases efficacy of delivered docetaxel against triple negative breast cancer.

In vivo and ex vivo proofs of concept that cetuximab conjugated vitamin E TPGS micelles increases efficacy of delivered docetaxel against triple negative breast cancer.

Item
http://www.wikidata.org/entity/Q38863183
D-α-tocopheryl polyethylene glycol 1000 succinate functionalized nanographene oxide for cancer therapy.Reiterated Targeting Peptides on the Nanoparticle Surface Significantly Promote Targeted Vascular Endothelial Growth Factor Gene Delivery to Stem Cells.TNF-α sensitizes chemotherapy and radiotherapy against breast cancer cells.Understanding and exploiting nanoparticles' intimacy with the blood vessel and blood.Transferrin liposomes of docetaxel for brain-targeted cancer applications: formulation and brain theranostics.Encapsulated paclitaxel nanoparticles exhibit enhanced anti-tumor efficacy in A549 non-small lung cancer cells.Transferrin receptor-targeted vitamin E TPGS micelles for brain cancer therapy: preparation, characterization and brain distribution in rats.A7RC peptide modified paclitaxel liposomes dually target breast cancer.Current trends in the use of vitamin E-based micellar nanocarriers for anticancer drug delivery.Sustained-releasing hollow microparticles with dual-anticancer drugs elicit greater shrinkage of tumor spheroids.αvβ3 integrin-targeted micellar mertansine prodrug effectively inhibits triple-negative breast cancer in vivo.Recent developments in d-α-tocopheryl polyethylene glycol-succinate-based nanomedicine for cancer therapy.Targeted imaging of EGFR overexpressed cancer cells by brightly fluorescent nanoparticles conjugated with cetuximab.Mesoporous carbon nanoshells for high hydrophobic drug loading, multimodal optical imaging, controlled drug release, and synergistic therapy.DNA Nanostructures Carrying Stoichiometrically Definable Antibodies.Overcoming Instability of Antibody-Nanomaterial Conjugates: Next Generation Targeted Nanomedicines Using Bispecific Antibodies.Eph A10-modified pH-sensitive liposomes loaded with novel triphenylphosphine-docetaxel conjugate possess hierarchical targetability and sufficient antitumor effect both in vitro and in vivo.
P2860

In vivo and ex vivo proofs of concept that cetuximab conjugated vitamin E TPGS micelles increases efficacy of delivered docetaxel against triple negative breast cancer.

Item
http://www.wikidata.org/entity/Q38863183
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
In vivo and ex vivo proofs of ...... triple negative breast cancer.
@en
type
label
In vivo and ex vivo proofs of ...... triple negative breast cancer.
@en
prefLabel
In vivo and ex vivo proofs of ...... triple negative breast cancer.
@en
P1433
P1476
P2093
P304
P31
P356
P478
P50
P577
P5875
P698
P921
P356
P1433
P1476
In vivo and ex vivo proofs of ...... triple negative breast cancer
@en
P2093
P304
P31
P356
10.1016/J.BIOMATERIALS.2015.06.005
P478
P50
P577
P5875
P698
P921